Original Article

You have full text access to this OnlineOpen article

Twelve-year mortality results of a randomized trial of 2 versus 5 years of adjuvant tamoxifen for postmenopausal early-stage breast carcinoma patients (SITAM 01)†‡

  1. Maurizio Belfiglio M.D.,
  2. Miriam Valentini M.D.,
  3. Fabio Pellegrini M.Sc.,
  4. Giorgia De Berardis M.Sc.,
  5. Monica Franciosi M.Sc.,
  6. Maria C.E. Rossi M.Sc.,
  7. Michele Sacco M.D.,
  8. Antonio Nicolucci M.D.§,*

Article first published online: 24 OCT 2005

DOI: 10.1002/cncr.21474

Issue

Cancer

Cancer

Volume 104, Issue 11, pages 2334–2339, 1 December 2005

Additional Information

How to Cite

Belfiglio, M., Valentini, M., Pellegrini, F., De Berardis, G., Franciosi, M., Rossi, M. C.E., Sacco, M. and Nicolucci, A. (2005), Twelve-year mortality results of a randomized trial of 2 versus 5 years of adjuvant tamoxifen for postmenopausal early-stage breast carcinoma patients (SITAM 01). Cancer, 104: 2334–2339. doi: 10.1002/cncr.21474

Author Information

  1. Department of Clinical Pharmacology and Epidemiology, Consorzio Mario Negri Sud, S. Maria Imbaro, Italy

  1. §

    Fax (011) 39 0872 570263

*Department of Clinical Pharmacology and Epidemiology, Consorzio Mario Negri Sud, Via Nazionale, 8/A – 66030 S. Maria Imbaro, Italy

  1. †

    Part of this study was presented in abstract form at the ASCO, 2005 Annual Meeting, Orlando, Florida 13–17 May, 2005.

  2. ‡

    Participating clinicians: Giampaolo Sacchetto, Loredana De Filippi, Alba (CN); Francesco Di Vito, Mariella Cucchi, Aosta; Giuseppe Di Biagio, Assisi (PG); Franco Testore, Asti; Luciano Isa, Gorgonzola (MI); Tonino Pedicini, Claudia Corbo, Antonio Febbraro, Benevento; Patrizia Marpicati, Giovanni Marini, Edda Simoncini, Brescia; Mario Costanzo, Catania; Ettore Cianchetti, Simona Grossi, Paolo Noccioli, Ortona (CH); Donata Tabiadon, Riccardo Valsecchi, Gino Luporini, Milano; Giordano Beretta, Cinisello Balsamo (MI); Fulvio Peradotto, Cuorgné (TO); Angelo Gambi, M. Cristina Cappelli, Flavia Foglietta, Faenza (RA); Monica Indelli, Caterina Modonesi, Ferrara; M. Antonietta De Meo, Giuseppe Cardi, Formia (LT); Giorgio Baratelli, Gravedona (CO); Liberato Di Lullo, Isernia; Giampaolo De Rubeis, L'Aquila; Stefano Graziani, Lanciano (CH); Michele Antonello, Giambeppi Pizzi, Mestre (VE); Elisa Locatelli, Milano; Vito Schena, Sergio Peonetto, Patrizia Grace Bianchi, Milano; Francesco Arceri, Novara; Paola Viola, Rho (MI); Mauro Antimi, Mauro Minelli, Vincenzo Bellini, Giuseppe Marinuzzi, Roma; Nina Olmeo, Antonio Contu, Sassari; Luciano Galletto, Marcella Sussio, Savigliano (CN); Fabrizio Fracchia, Raffaella Fiorella, Torino; Giorgio Giardina, Torino; Maria Grazia Pacquola, Anna Tava, Tortona (AL); Antonella Richetti, Marinella Molteni, Varese; Riccardo Samaritani, Roma; Attilio D'Arrigo, Ivrea (TO); Enrico Ansaldi, Cirié (TO); Sano Pasqualucci, Carlo Floris, Maria Cristina Cherchi, Enrichetta Valle, Cagliari; Italo Rasciale, Antonello Conte, Lorena Biasizzo, Udine; Antonio Tedde, Alberto Desogus, Marco Pintus, Cagliari; Giovanni Ambrosini, Orazio Caffo, Trento; Aurora Ferrari, Vittorio Corsetti, Ileana Capata, Calcinato (BS); Pietro Masullo, Francesco D'Episcopo, Vallo della Lucania (SA); Giorgio Mustacchi, Michela Muggia, Trieste; Maria Concetta Chetrí, Brindisi; Giuseppe Serravezza, Antonella Elia, Giuseppe Quarta, Casarano (LE); Stefano Bravi, Franco Biagioni, Città di Castello (PG); Antonio Rulli, Annarita Vento, Paola Naninato, Perugia; Virginia Liguori, Candida Mastroianni, Salvatore Palazzo, Cosenza; Enza Defabiani, Mario Campogrande, Torino.

Publication History

  1. Issue published online: 18 NOV 2005
  2. Article first published online: 24 OCT 2005
  3. Manuscript Accepted: 6 JUL 2005
  4. Manuscript Revised: 8 JUN 2005
  5. Manuscript Received: 14 APR 2005

Funded by

  • AstraZeneca Italia

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (92K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Shannon Puhalla, Saveri Bhattacharya, Nancy E. Davidson, Hormonal therapy in breast cancer: A model disease for the personalization of cancer care, Molecular Oncology, 2012, 6, 2, 222

    CrossRef

  2. 2
    Shannon Puhalla, Adam Brufsky, Nancy Davidson, Adjuvant endocrine therapy for premenopausal women with breast cancer, The Breast, 2009, 18, S122

    CrossRef

  3. 3
    Seema Harichand-Herdt, Amelia Zelnak, Ruth O’Regan, Endocrine therapy for the treatment of postmenopausal women with breast cancer, Expert Review of Anticancer Therapy, 2009, 9, 2, 187

    CrossRef

  4. 4
    H.E. Fjøsne, A.-B. Jacobsen, S. Lundgren, Adjuvant cyclic Tamoxifen and Megestrol acetate treatment in postmenopausal breast cancer patients – Longterm follow-up, European Journal of Surgical Oncology (EJSO), 2008, 34, 1, 6

    CrossRef

  5. 5
    Shigehira Saji, Katsumasa Kuroi, Application of selective estrogen receptor modulators for breast cancer treatment according to their intrinsic nature, Breast Cancer, 2008, 15, 4, 262

    CrossRef

  6. 6
    Peng H Tan, Amrit S Lota, Interaction of current cancer treatments and the immune system: implications for breast cancer therapeutics, Expert Opinion on Pharmacotherapy, 2008, 9, 15, 2639

    CrossRef

  7. 7
    Tessa Cigler, Paul E. Goss, Breast Cancer Adjuvant Endocrine Therapy, The Cancer Journal, 2007, 13, 3, 148

    CrossRef

  8. 8
    Manuela Rabaglio, Stefan Aebi, Monica Castiglione-Gertsch, Controversies of adjuvant endocrine treatment for breast cancer and recommendations of the 2007 St Gallen conference, The Lancet Oncology, 2007, 8, 10, 940

    CrossRef

  9. 9
    Maurizio Belfiglio, Miriam Valentini, Antonio Nicolucci, Author reply, Cancer, 2006, 107, 1
    Direct Link:
  10. 10
    Scientific surgery, British Journal of Surgery, 2006, 93, 6
    Direct Link:
  11. 11
    Carol Alliot, Twelve-year mortality results of a randomized trial of 2 versus 5 years of adjuvant tamoxifen for postmenopausal early-stage breast carcinoma patients (SITAM 01), Cancer, 2006, 107, 1
    Direct Link:
View Full Article (HTML) Get PDF (92K)